showed a trendp=0.17
All of those with a BMI ≥25.0 versus healthy BMI showed a trend toward requiring a larger total gonadotrophin dose (SMD=0.21, 95% CIs −0.09 to 0.51, p=0.17) ( online supplemental figure 2C ).
All of those with a BMI ≥25.0 versus healthy BMI showed a trend toward requiring a larger total gonadotrophin dose (SMD=0.21, 95% CIs −0.09 to 0.51, p=0.17) ( online supplemental figure 2C ).
No significant differences in LBR were identified between healthy and overweight BMI (OR 1.27, 95% CIs 0.97 to 1.67, p=0.09) ( online supplemental figure 5A ) or healthy and obese BMI (OR 1.20, 95% CIs 0.81 to 1.80, p=0.37) ( online supplemental figure 5B ), but an obvious trend towards favouring healthy weight can be seen ( online supplemental figure 5A and B ).
However, an overall trend of increasing total gonadotrophin dose with increasing BMI was observed in obese females ( online supplemental figure 2B ).